Manufactured in cGMP certified facilities
Interstitial cystitis: In a trial of 12 women (ages 39-76) with moderate to severe interstitial cystitis unresponsive to conventional treatment, a single 10 mg BPC-157 injection led to complete symptom resolution in 10 patients and 80% improvement in 2, with no reported adverse effects (18) Knee pain: A retrospective study found that 11 of the 12 patients (91.6%) receiving BPC 157 as an intra-articular injection had significant improvement in knee pain, whereas 1 patient (8.3 %) had no improvement (19) Efficacy of BPC 157 Delivery Methods BPC-157 can be administered orally, topically, or via injection
At Perfect B, we set explicit return-to-activity protocols at the intake that are based on the tissue type, the severity of the injury, and the expected structural healing timeline, not on when the patient stops feeling pain
There is also ongoing research into peptide activity in areas such as growth hormone release, metabolic regulation, and skin appearance
A history of regulatory animal testing: what can we learn
